Significant increase in revenue from faster NDIS approvals
Filed with ASX · · 3 pages · English
Earlier from Control Bionics
- Addendum to notice of 2024 agm
- Placement
- Non-renounceable rights issue offer and private placement ad
- Non-Renounceable Issue
- Investor Presentation
Later from Control Bionics
- Coffee Microcaps Meeting Presentation
- Expansion into US Sports and Japanese Rehab Markets
- First Half FY25 Business Update
- Private Placement
- FY25 Trading Update and NeuroStrip Progress
Follow Control Bionics into a list and get an email when it puts out news.
Follow Control Bionics